Recruiting NA INTERVENTIONAL 1-arm NCT04035642

Phase II Study of Single-Dose Image-Guided Radiotherapy (SDRT) for Prostate Cancer (PROSINT II)

Phase II Study of Single-Dose Image-Guided Radiotherapy (SDRT) With Urethral Sparing for Localized Prostate Cancer

Sponsor: Fundacao Champalimaud

Interventions IGRT 24 Gy Single dose Image-guided, volumetric intensity-modulated arc radiotherapy (IGRT-VMAT) Rectal balloon with air filling Urethral catheter loaded with beacon transponders

Updated 5 times since 2019 Last updated: Jul 25, 2019 Started: Jun 1, 2019 Primary completion: Jun 30, 2021 Completion: Jun 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Prostate Cancer and is currently actively recruiting participants. Fundacao Champalimaud leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Sep 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2021 — Jul 2024 [monthly]

Recruiting NA
Aug 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundacao Champalimaud

Data source: Fundacao Champalimaud

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lisbon, Portugal